43 related articles for article (PubMed ID: 34319022)
1. Clinical Implications of mTOR Expression in Papillary Thyroid Cancer-A Systematic Review.
Derwich A; Sykutera M; Bromińska B; Andrusiewicz M; Ruchała M; Sawicka-Gutaj N
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980552
[TBL] [Abstract][Full Text] [Related]
2. VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma.
Todorović L; Stanojević B
Biomol Biomed; 2023 Feb; 23(1):26-36. PubMed ID: 36036061
[TBL] [Abstract][Full Text] [Related]
3. The Association of the BRAF-V600E Mutation with the Expression of the Molecular Markers in the Primary Tumor and Metastatic Tissue in Papillary Thyroid Cancer.
Spirina LV; Chizhevskaya SY; Kovaleva IV; Kondakova IV
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2017-2024. PubMed ID: 34319022
[TBL] [Abstract][Full Text] [Related]
4. Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression.
Gandolfi G; Sancisi V; Torricelli F; Ragazzi M; Frasoldati A; Piana S; Ciarrocchi A
J Clin Endocrinol Metab; 2013 May; 98(5):E934-42. PubMed ID: 23533235
[TBL] [Abstract][Full Text] [Related]
5. The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation.
Chernaya G; Mikhno N; Khabalova T; Svyatchenko S; Mostovich L; Shevchenko S; Gulyaeva L
Surg Oncol; 2018 Dec; 27(4):702-708. PubMed ID: 30449496
[TBL] [Abstract][Full Text] [Related]
6. Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature.
Krishnamurthy A; Ramshankar V; Murherkar K; Vidyarani S; Raghunandhan GC; Das A; Desai PB; Albert K
Indian J Cancer; 2017; 54(1):372-378. PubMed ID: 29199726
[TBL] [Abstract][Full Text] [Related]
7. BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas.
Durante C; Tallini G; Puxeddu E; Sponziello M; Moretti S; Ligorio C; Cavaliere A; Rhoden KJ; Verrienti A; Maranghi M; Giacomelli L; Russo D; Filetti S
Eur J Endocrinol; 2011 Sep; 165(3):455-63. PubMed ID: 21653734
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of the BRAF V600E mutation in papillary thyroid carcinoma. Evaluation against real-time polymerase chain reaction.
Paja Fano M; Ugalde Olano A; Fuertes Thomas E; Oleaga Alday A
Endocrinol Diabetes Nutr; 2017 Feb; 64(2):75-81. PubMed ID: 28440781
[TBL] [Abstract][Full Text] [Related]
9. BRAF V600E and lymph node metastases in papillary thyroid cancer.
Chen P; Pan L; Huang W; Feng H; Ouyang W; Wu J; Wang J; Deng Y; Luo J; Chen Y
Endocr Connect; 2020 Oct; 9(10):999-1008. PubMed ID: 33064665
[TBL] [Abstract][Full Text] [Related]
10. The
Ge J; Wang J; Wang H; Jiang X; Liao Q; Gong Q; Mo Y; Li X; Li G; Xiong W; Zhao J; Zeng Z
J Cancer; 2020; 11(4):932-939. PubMed ID: 31949496
[No Abstract] [Full Text] [Related]
11. Molecular Heterogeneity of Papillary Thyroid Cancer: Comparison of Primary Tumors and Synchronous Metastases in Regional Lymph Nodes by Mass Spectrometry Imaging.
Gawin M; Kurczyk A; Stobiecka E; Frątczak K; Polańska J; Pietrowska M; Widłak P
Endocr Pathol; 2019 Dec; 30(4):250-261. PubMed ID: 31664609
[TBL] [Abstract][Full Text] [Related]
12. Transcription factors Brn-3α and TRIM16 in cancers, association with hormone reception.
Spirina LV; Yunusova NV; Kondakova IV; Tarasenko NV
Heliyon; 2019 Aug; 5(8):e02090. PubMed ID: 31463379
[TBL] [Abstract][Full Text] [Related]
13.
Bhagirath D; Yang TL; Tabatabai ZL; Majid S; Dahiya R; Tanaka Y; Saini S
Clin Cancer Res; 2019 Nov; 25(21):6532-6545. PubMed ID: 31371344
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
